Cyclin-dependent kinases

M Malumbres - Genome biology, 2014 - Springer
Cyclin-dependent kinases (CDKs) are protein kinases characterized by needing a separate
subunit-a cyclin-that provides domains essential for enzymatic activity. CDKs play important …

[HTML][HTML] Targeting CDK2 in cancer: challenges and opportunities for therapy

S Tadesse, AT Anshabo, N Portman, E Lim, W Tilley… - Drug discovery today, 2020 - Elsevier
Highlights•CDK2 has key roles in cell cycle, DNA replication and DNA damage.•Multiple
biomarkers can indicate increased CDK2 activity.•Some cancers have particular …

Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity

M Arora, J Moser, TE Hoffman, LP Watts, M Min… - Cell, 2023 - cell.com
CDK2 is a core cell-cycle kinase that phosphorylates many substrates to drive progression
through the cell cycle. CDK2 is hyperactivated in multiple cancers and is therefore an …

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

S Lim, P Kaldis - Development, 2013 - journals.biologists.com
Cyclin-dependent kinases (Cdks) are serine/threonine kinases and their catalytic activities
are modulated by interactions with cyclins and Cdk inhibitors (CKIs). Close cooperation …

[HTML][HTML] Myc and cell cycle control

G Bretones, MD Delgado, J León - Biochimica et Biophysica Acta (BBA) …, 2015 - Elsevier
Soon after the discovery of the Myc gene (c-Myc), it became clear that Myc expression levels
tightly correlate to cell proliferation. The entry in cell cycle of quiescent cells upon Myc …

[HTML][HTML] Inhibitors of cyclin-dependent kinases as cancer therapeutics

SR Whittaker, A Mallinger, P Workman… - Pharmacology & …, 2017 - Elsevier
Over the past two decades there has been a great deal of interest in the development of
inhibitors of the cyclin-dependent kinases (CDKs). This attention initially stemmed from …

Strategies to inhibit Myc and their clinical applicability

JR Whitfield, ME Beaulieu, L Soucek - Frontiers in cell and …, 2017 - frontiersin.org
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …

Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB

V Tripathi, Z Shen, A Chakraborty, S Giri… - PLoS …, 2013 - journals.plos.org
The long noncoding MALAT1 RNA is upregulated in cancer tissues and its elevated
expression is associated with hyper-proliferation, but the underlying mechanism is poorly …

CDK4/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1/S transition

S Kim, A Leong, M Kim, HW Yang - Scientific reports, 2022 - nature.com
External signaling controls cell-cycle entry until cells irreversibly commit to the cell cycle to
ensure faithful DNA replication. This process is tightly regulated by cyclin-dependent …

Cell cycle, CDKs and cancer: a changing paradigm

M Malumbres, M Barbacid - Nature reviews cancer, 2009 - nature.com
Tumour-associated cell cycle defects are often mediated by alterations in cyclin-dependent
kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as …